Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Beattie

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Brain Research|January 9, 1995
Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptideK J Escott, D T Beattie, H E Connor, et al.
Neuropeptides|September 1, 1995
The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicinK J Escott, H E Connor, S D Brain, et al.
Acta Chemica Scandinavica (Copenhagen, Denmark : 1989)|January 1, 1990
Synthesis and single cell pharmacology of potential heterocyclic bioisosteres of the excitatory amino acid antagonist glutamic acid diethyl esterU Madsen, E O Nielsen, D R Curtis, et al.
Neuroscience Letters|September 23, 1988
Baclofen antagonism by 2-hydroxy-saclofen in the cat spinal cordD R Curtis, B D Gynther, D T Beattie, et al.
Regulatory Peptides|January 15, 1997
The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular systemJ S Polley, P J Gaskin, M J Perren, et al.
Journal of Bacteriology|February 1, 1992
Constitutive sensory transduction mutations in the Bordetella pertussis bvgS geneJ F Miller, S A Johnson, W J Black, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 7, 2007
The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexoneD T Beattie, M Cheruvu, N Mai, et al.
Behavioural Brain Research|January 1, 1996
GR127935: a potent and selective 5-HT1D receptor antagonistM Skingle, D T Beattie, D I Scopes, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 17, 2008
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activityJ A M Smith, D T Beattie, D Marquess, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response studyM Goldberg, Y-P Li, J F Johanson, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Brain Research|January 9, 1995
Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptideK J Escott, D T Beattie, H E Connor, et al.
Neuropeptides|September 1, 1995
The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicinK J Escott, H E Connor, S D Brain, et al.
Acta Chemica Scandinavica (Copenhagen, Denmark : 1989)|January 1, 1990
Synthesis and single cell pharmacology of potential heterocyclic bioisosteres of the excitatory amino acid antagonist glutamic acid diethyl esterU Madsen, E O Nielsen, D R Curtis, et al.
Neuroscience Letters|September 23, 1988
Baclofen antagonism by 2-hydroxy-saclofen in the cat spinal cordD R Curtis, B D Gynther, D T Beattie, et al.
Regulatory Peptides|January 15, 1997
The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular systemJ S Polley, P J Gaskin, M J Perren, et al.
Journal of Bacteriology|February 1, 1992
Constitutive sensory transduction mutations in the Bordetella pertussis bvgS geneJ F Miller, S A Johnson, W J Black, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 7, 2007
The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexoneD T Beattie, M Cheruvu, N Mai, et al.
Behavioural Brain Research|January 1, 1996
GR127935: a potent and selective 5-HT1D receptor antagonistM Skingle, D T Beattie, D I Scopes, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 17, 2008
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activityJ A M Smith, D T Beattie, D Marquess, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2010
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response studyM Goldberg, Y-P Li, J F Johanson, et al.
Pageof 5